TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma
Li, J.; Huang, K.; McBride, F.; Sadagopan, A.; Gallant, D. S.; Thakur, M.; Khanna, P.; Li, B.; Ge, M.; Weiss, C. N.; Achom, M.; Xu, Q.; Huang, K.; Ryback, B. A.; Gui, M.; bar-peled, l.; Viswanathan, S. R.
Show abstract
Translocation renal cell carcinoma (tRCC) is an aggressive subtype of kidney cancer driven by TFE3 gene fusions, which act via poorly characterized downstream mechanisms. Here we report that TFE3 fusions transcriptionally rewire tRCCs toward oxidative phosphorylation (OXPHOS), contrasting with the highly glycolytic metabolism of most other renal cancers. This TFE3 fusion-driven OXPHOS program, together with heightened glutathione levels found in renal cancers, renders tRCCs sensitive to reductive stress - a metabolic stress state induced by an imbalance of reducing equivalents. Genome-scale CRISPR screening identifies tRCC-selective vulnerabilities linked to this metabolic state, including EGLN1, which hydroxylates HIF-1 and targets it for proteolysis. Inhibition of EGLN1 compromises tRCC cell growth by stabilizing HIF-1a and promoting metabolic reprogramming away from OXPHOS, thus representing a vulnerability to OXPHOS-dependent tRCC cells. Our study defines a distinctive tRCC-essential metabolic program driven by TFE3 fusions and nominates EGLN1 inhibition as a therapeutic strategy to counteract fusion-induced metabolic rewiring.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer 97%
- Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells 96%
- An immunomechanical checkpoint PYK2 governs monocyte-to-macrophage differentiation in pancreatic cancer 96%
Similar papers in this journal
- ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination deficient cells 97%
- BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 97%
- Glucosylceramide induced ectosomes propagate pathogenic α-synuclein in Parkinson's disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.